Una S Ryan - Net Worth and Insider Trading
Una S Ryan Net Worth
The estimated net worth of Una S Ryan is at least $309,617 dollars as of 2024-11-09. Una S Ryan is the Director of Albany Molecular Research Inc and owns about 14,017 shares of Albany Molecular Research Inc (AMRI) stock worth over $304,730. Una S Ryan is also the Director of Quince Therapeutics Inc and owns about 2,875 shares of Quince Therapeutics Inc (QNCX) stock worth over $4,888. Details can be seen in Una S Ryan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Una S Ryan has not made any transactions after 2019-05-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Una S Ryan
Una S Ryan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Una S Ryan owns 4 companies in total, including Quince Therapeutics Inc (QNCX) , Albany Molecular Research Inc (AMRI) , and Celldex Therapeutics Inc (CLDX) among others .
Click here to see the complete history of Una S Ryan’s form 4 insider trades.
Insider Ownership Summary of Una S Ryan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2019-05-13 | director |
| AMRI | Albany Molecular Research Inc | 2017-05-10 | director |
| CLDX | Celldex Therapeutics Inc | 2003-07-24 | director & President & CEO |
 | | 2021-10-01 | director |
Una S Ryan Latest Holdings Summary
Una S Ryan currently owns a total of 2 stocks. Among these stocks, Una S Ryan owns 14,017 shares of Albany Molecular Research Inc (AMRI) as of May 22, 2012, with a value of $304,730 and a weighting of 98.42%. Una S Ryan also owns 2,875 shares of Quince Therapeutics Inc (QNCX) as of May 13, 2019, with a value of $4,888 and a weighting of 1.58%.
Latest Holdings of Una S Ryan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AMRI | Albany Molecular Research Inc | 2012-05-22 | 14,017 | 21.74 | 304,730 |
| QNCX | Quince Therapeutics Inc | 2019-05-13 | 2,875 | 1.70 | 4,888 |
Holding Weightings of Una S Ryan
Una S Ryan Form 4 Trading Tracker
According to the SEC Form 4 filings, Una S Ryan has made a total of 0 transactions in Albany Molecular Research Inc (AMRI) over the past 5 years. The most-recent trade in Albany Molecular Research Inc is the acquisition of 200 shares on May 22, 2012, which cost Una S Ryan around $562.
According to the SEC Form 4 filings, Una S Ryan has made a total of 0 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years. The most-recent trade in Quince Therapeutics Inc is the acquisition of 2,875 shares on May 13, 2019, which cost Una S Ryan around $48,875.
Insider Trading History of Una S Ryan
- 1
Una S Ryan Trading Performance
GuruFocus tracks the stock performance after each of Una S Ryan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Una S Ryan is 18.93%. GuruFocus also compares Una S Ryan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Una S Ryan within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Una S Ryan's insider trading performs compared to the benchmark.
Performance of Una S Ryan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.4 | | | | | |
| Relative Return to S&P 500(%) | 10.28 | | | | | |
Una S Ryan Ownership Network
Ownership Network List of Una S Ryan
Ownership Network Relation of Una S Ryan
Una S Ryan Owned Company Details
What does Quince Therapeutics Inc do?
Who are the key executives at Quince Therapeutics Inc?
Una S Ryan is the director of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include director & Chief Executive Officer Dirk Thye , Chief Business Officer Brendan Hannah , and President Charles S. Ryan .
Quince Therapeutics Inc (QNCX) Insider Trades Summary
Over the past 18 months, Una S Ryan made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 322,500 shares made by Dirk Thye , and a net purchase of 110,686 shares made by Brendan Hannah .
In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 241,811 shares, with a net purchase of 241,811 shares. During the past 18 months, 0 shares of Quince Therapeutics Inc (QNCX) were sold and 990,009 shares were bought by its insiders, resulting in a net purchase of 990,009 shares.
Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quince Therapeutics Inc Insider Transactions
Una S Ryan Mailing Address
Above is the net worth, insider trading, and ownership report for Una S Ryan. You might contact Una S Ryan via mailing address: 329 Hammond Street, Chestnut Hill Ma 02467.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
